What would it be like to meet the inventor of the investigational drug that is keeping you alive? Janet Freeman-Daily found out firsthand at the 2014 ASCO Annual Meeting.
Research Highlights on Immunotherapy for Melanoma and Cervical Cancer From the 2014 ASCO Annual Meeting
Activating and amplifying the body’s immune response to cancer is an exciting area of research. See how it is being used to better treat advanced or high-risk melanoma and cervical cancer in these four studies presented in Chicago today.
Get highlights of four pivotal studies that reveal new ways to optimize commonly used chemotherapy, hormone therapy, and newer targeted drugs, and answer critical questions about the effectiveness of two common treatment regimens for advanced colorectal cancer.
Learn more about four studies that show the potential of new targeted therapies for advanced ovarian, lung, and thyroid cancers and chronic lymphocytic leukemia.
New Strategies to Improve Quality of Life for Patients, Survivors, and Caregivers From the 2014 ASCO Annual Meeting
Researchers are continuing to find new ways to reduce the side effects of treatment and improve quality of life. Get highlights of five studies presented today at the ASCO Annual Meeting.
In this podcast, you’ll learn about key definitions and categories of cancer research studies. It also has tips for finding medical journals.
Get highlights of five studies showing promise in novel targeted therapies, cancer prevention, and patient care that will be presented at ASCO’s 50th Annual Meeting.
There are many pills, powders, creams, and herbs available on the Internet that claim to treat or even cure cancer. What can you believe? And what are the red flags to watch out for?
Cancer.Net’s Editor-in-Chief, Robert Miller, talks with patient advocate Wendy Poage about her experience at the 2014 GU Symposium.
Kidney cancer patient advocate Berit Eberhardt describes why she traveled more than 5,000 miles to attend the 2014 Genitourinary Cancers Symposium.